|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/4439 | (2013.01) | ||
| C07D 401/14 | (2006.01) | ||
| A61K 31/4725 | (2013.01) | ||
| A61K 31/496 | (2013.01) | ||
| C07D 403/04 | (2006.01) | ||
| C07D 207/452 | (2013.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 417/12 | (2006.01) | ||
| C07D 207/50 | (2013.01) | ||
| C07D 207/452 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| C07D 401/14 | (2013.01) | ||
| A61K 31/4725 | (2006.01) | ||
| C07D 403/04 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 405/14 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| C07D 417/12 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3567035 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19167943.0 |
| Date of filing the European patent application | 2008-04-11 | |
| (97) | Date of publication of the European application | 2019-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 911258 P | 2007-04-11 | US |
| (72) |
KAWABE, Takumi , JP
ISHIGAKI, Machiyo , JP
SATO, Takuji , JP
YAMAMOTO, Sayaka , JP
HASEGAWA, Yoko , JP
|
| (73) |
CanBas Co., Ltd. ,
2-2-1, Otemachi, Numazu
Shizuoka 410-0801,
JP
|
| (54) | N-SUBSTITUTED 2,5-DIOXO-AZOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER |
| N-SUBSTITUTED 2,5-DIOXO-AZOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER |